4//SEC Filing
Daniels Mark 4
Accession 0001214659-21-002670
CIK 0001581280other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:36 PM ET
Size
12.9 KB
Accession
0001214659-21-002670
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Exercise/Conversion
Common Stock
2021-03-01$26.66/sh+1,166$31,086→ 68,092 total - Exercise/Conversion
Common Stock
2021-03-01$8.82/sh+377$3,325→ 68,469 total - Sale
Common Stock
2021-03-01$140.78/sh−1,543$217,224→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-01−1,166→ 37,344 totalExercise: $26.66Exp: 2028-11-18→ Common Stock (1,166 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-01−377→ 2,638 totalExercise: $8.82Exp: 2027-09-28→ Common Stock (377 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753840
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:36 PM ET
- Size
- 12.9 KB